nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—ADRA1A—hypertension	0.242	1	CbGaD
Midodrine—SLC15A1—Quinapril—hypertension	0.026	0.0494	CbGbCtD
Midodrine—SLC15A1—Fosinopril—hypertension	0.026	0.0494	CbGbCtD
Midodrine—SLC15A1—Benazepril—hypertension	0.0232	0.044	CbGbCtD
Midodrine—SLC15A1—Moexipril—hypertension	0.0232	0.044	CbGbCtD
Midodrine—SLC15A1—Methyldopa—hypertension	0.0232	0.044	CbGbCtD
Midodrine—ADRA1D—Terazosin—hypertension	0.0215	0.0408	CbGbCtD
Midodrine—ADRA1D—Fenoldopam—hypertension	0.0195	0.0369	CbGbCtD
Midodrine—ADRA1D—Doxazosin—hypertension	0.018	0.0341	CbGbCtD
Midodrine—SLC15A1—Trandolapril—hypertension	0.0176	0.0333	CbGbCtD
Midodrine—SLC15A1—Perindopril—hypertension	0.0161	0.0305	CbGbCtD
Midodrine—ADRA1B—Terazosin—hypertension	0.0157	0.0297	CbGbCtD
Midodrine—ADRA1D—Prazosin—hypertension	0.0148	0.028	CbGbCtD
Midodrine—ADRA1B—Fenoldopam—hypertension	0.0142	0.0269	CbGbCtD
Midodrine—SLC15A1—Enalapril—hypertension	0.0133	0.0253	CbGbCtD
Midodrine—SLC15A1—Lisinopril—hypertension	0.0133	0.0253	CbGbCtD
Midodrine—SLC15A1—Ramipril—hypertension	0.0133	0.0253	CbGbCtD
Midodrine—ADRA1B—Doxazosin—hypertension	0.0131	0.0248	CbGbCtD
Midodrine—ADRA1D—Carvedilol—hypertension	0.0127	0.0242	CbGbCtD
Midodrine—ADRA1D—Nicardipine—hypertension	0.0127	0.0242	CbGbCtD
Midodrine—ADRA1A—Terazosin—hypertension	0.0124	0.0235	CbGbCtD
Midodrine—ADRA1D—Clonidine—hypertension	0.0112	0.0212	CbGbCtD
Midodrine—ADRA1A—Fenoldopam—hypertension	0.0112	0.0212	CbGbCtD
Midodrine—ADRA1B—Prazosin—hypertension	0.0107	0.0204	CbGbCtD
Midodrine—ADRA1A—Doxazosin—hypertension	0.0103	0.0196	CbGbCtD
Midodrine—SLC15A1—Captopril—hypertension	0.00998	0.0189	CbGbCtD
Midodrine—ADRA1B—Nicardipine—hypertension	0.00928	0.0176	CbGbCtD
Midodrine—ADRA1B—Carvedilol—hypertension	0.00928	0.0176	CbGbCtD
Midodrine—ADRA1B—vas deferens—hypertension	0.00896	0.601	CbGeAlD
Midodrine—ADRA1A—Prazosin—hypertension	0.00848	0.0161	CbGbCtD
Midodrine—ADRA1B—Clonidine—hypertension	0.00814	0.0154	CbGbCtD
Midodrine—ADRA1A—Carvedilol—hypertension	0.00732	0.0139	CbGbCtD
Midodrine—ADRA1A—Nicardipine—hypertension	0.00732	0.0139	CbGbCtD
Midodrine—ADRA1A—Clonidine—hypertension	0.00643	0.0122	CbGbCtD
Midodrine—CYP2D6—Labetalol—hypertension	0.00537	0.0102	CbGbCtD
Midodrine—CYP2D6—Nebivolol—hypertension	0.00537	0.0102	CbGbCtD
Midodrine—CYP2D6—Acebutolol—hypertension	0.00491	0.00931	CbGbCtD
Midodrine—CYP2D6—Metoprolol—hypertension	0.00456	0.00865	CbGbCtD
Midodrine—CYP2D6—Pindolol—hypertension	0.00456	0.00865	CbGbCtD
Midodrine—CYP2D6—Betaxolol—hypertension	0.00407	0.00771	CbGbCtD
Midodrine—CYP2D6—Doxazosin—hypertension	0.00358	0.00679	CbGbCtD
Midodrine—CYP2D6—Diltiazem—hypertension	0.00346	0.00656	CbGbCtD
Midodrine—CYP2D6—Bepridil—hypertension	0.00308	0.00584	CbGbCtD
Midodrine—CYP2D6—Irbesartan—hypertension	0.00282	0.00535	CbGbCtD
Midodrine—CYP2D6—Amlodipine—hypertension	0.00277	0.00524	CbGbCtD
Midodrine—CYP2D6—Felodipine—hypertension	0.00267	0.00505	CbGbCtD
Midodrine—CYP2D6—Timolol—hypertension	0.00262	0.00497	CbGbCtD
Midodrine—CYP2D6—Nifedipine—hypertension	0.00258	0.00489	CbGbCtD
Midodrine—CYP2D6—Carvedilol—hypertension	0.00254	0.00481	CbGbCtD
Midodrine—CYP2D6—Nicardipine—hypertension	0.00254	0.00481	CbGbCtD
Midodrine—CYP2D6—Propranolol—hypertension	0.00234	0.00443	CbGbCtD
Midodrine—CYP2D6—Captopril—hypertension	0.00231	0.00438	CbGbCtD
Midodrine—CYP2D6—Clonidine—hypertension	0.00223	0.00423	CbGbCtD
Midodrine—CYP2D6—Atorvastatin—hypertension	0.00199	0.00377	CbGbCtD
Midodrine—CYP2D6—Verapamil—hypertension	0.0016	0.00304	CbGbCtD
Midodrine—Methoxamine—ADRA1A—hypertension	0.000803	0.275	CrCbGaD
Midodrine—CYP2D6—urine—hypertension	0.000737	0.0495	CbGeAlD
Midodrine—Melatonin—CALM2—hypertension	0.000617	0.211	CrCbGaD
Midodrine—Agomelatine—HTR2B—hypertension	0.000578	0.198	CrCbGaD
Midodrine—SLC15A1—nephron tubule—hypertension	0.000566	0.0379	CbGeAlD
Midodrine—ADRA1B—kidney—hypertension	0.000527	0.0354	CbGeAlD
Midodrine—SLC15A1—kidney—hypertension	0.000497	0.0334	CbGeAlD
Midodrine—Melatonin—CALM1—hypertension	0.000397	0.136	CrCbGaD
Midodrine—ADRA1A—brainstem—hypertension	0.000371	0.0249	CbGeAlD
Midodrine—ADRA1D—endocrine gland—hypertension	0.000361	0.0242	CbGeAlD
Midodrine—SLC15A1—endocrine gland—hypertension	0.000349	0.0234	CbGeAlD
Midodrine—ADRA1B—central nervous system—hypertension	0.000333	0.0223	CbGeAlD
Midodrine—ADRA1D—central nervous system—hypertension	0.000326	0.0219	CbGeAlD
Midodrine—ADRA1A—heart—hypertension	0.000321	0.0215	CbGeAlD
Midodrine—ADRA1A—cardiovascular system—hypertension	0.000303	0.0203	CbGeAlD
Midodrine—ADRA1A—adrenal gland—hypertension	0.000239	0.0161	CbGeAlD
Midodrine—CYP2D6—brainstem—hypertension	0.000218	0.0147	CbGeAlD
Midodrine—Melatonin—MPO—hypertension	0.000216	0.074	CrCbGaD
Midodrine—ADRA1A—endocrine gland—hypertension	0.000208	0.0139	CbGeAlD
Midodrine—ADRA1A—central nervous system—hypertension	0.000187	0.0126	CbGeAlD
Midodrine—Melatonin—CYP19A1—hypertension	0.000176	0.0603	CrCbGaD
Midodrine—CYP2D6—kidney—hypertension	0.000174	0.0117	CbGeAlD
Midodrine—Melatonin—CYP1A1—hypertension	0.00013	0.0444	CrCbGaD
Midodrine—CYP2D6—endocrine gland—hypertension	0.000122	0.0082	CbGeAlD
Midodrine—CYP2D6—central nervous system—hypertension	0.00011	0.00739	CbGeAlD
Midodrine—Dyspepsia—Hydrochlorothiazide—hypertension	4.15e-05	0.0003	CcSEcCtD
Midodrine—Nervousness—Lisinopril—hypertension	4.14e-05	0.0003	CcSEcCtD
Midodrine—Dizziness—Diltiazem—hypertension	4.14e-05	0.000299	CcSEcCtD
Midodrine—Dizziness—Indapamide—hypertension	4.14e-05	0.000299	CcSEcCtD
Midodrine—Gastrointestinal pain—Telmisartan—hypertension	4.14e-05	0.000299	CcSEcCtD
Midodrine—Back pain—Lisinopril—hypertension	4.13e-05	0.000298	CcSEcCtD
Midodrine—Somnolence—Furosemide—hypertension	4.13e-05	0.000298	CcSEcCtD
Midodrine—Paraesthesia—Betaxolol—hypertension	4.13e-05	0.000298	CcSEcCtD
Midodrine—Gastrointestinal disorder—Perindopril—hypertension	4.12e-05	0.000298	CcSEcCtD
Midodrine—Gastrointestinal disorder—Irbesartan—hypertension	4.11e-05	0.000297	CcSEcCtD
Midodrine—Muscle spasms—Lisinopril—hypertension	4.1e-05	0.000296	CcSEcCtD
Midodrine—Dizziness—Carvedilol—hypertension	4.1e-05	0.000296	CcSEcCtD
Midodrine—Dyspnoea—Betaxolol—hypertension	4.1e-05	0.000296	CcSEcCtD
Midodrine—Pain—Perindopril—hypertension	4.08e-05	0.000295	CcSEcCtD
Midodrine—Rash—Propranolol—hypertension	4.08e-05	0.000295	CcSEcCtD
Midodrine—Dermatitis—Propranolol—hypertension	4.07e-05	0.000294	CcSEcCtD
Midodrine—Abdominal pain—Trandolapril—hypertension	4.07e-05	0.000294	CcSEcCtD
Midodrine—Pain—Irbesartan—hypertension	4.07e-05	0.000294	CcSEcCtD
Midodrine—Abdominal pain—Enalapril—hypertension	4.05e-05	0.000293	CcSEcCtD
Midodrine—Dizziness—Doxazosin—hypertension	4.05e-05	0.000293	CcSEcCtD
Midodrine—Feeling abnormal—Captopril—hypertension	4.05e-05	0.000293	CcSEcCtD
Midodrine—Insomnia—Losartan—hypertension	4.05e-05	0.000293	CcSEcCtD
Midodrine—Dyspepsia—Betaxolol—hypertension	4.05e-05	0.000292	CcSEcCtD
Midodrine—Pain—Hydrochlorothiazide—hypertension	4.04e-05	0.000292	CcSEcCtD
Midodrine—Paraesthesia—Losartan—hypertension	4.02e-05	0.000291	CcSEcCtD
Midodrine—Gastrointestinal pain—Captopril—hypertension	4.02e-05	0.000291	CcSEcCtD
Midodrine—Gastrointestinal disorder—Furosemide—hypertension	4.01e-05	0.00029	CcSEcCtD
Midodrine—Dizziness—Fosinopril—hypertension	4e-05	0.000289	CcSEcCtD
Midodrine—Abdominal pain—Telmisartan—hypertension	4e-05	0.000289	CcSEcCtD
Midodrine—Dyspnoea—Losartan—hypertension	3.99e-05	0.000289	CcSEcCtD
Midodrine—Anxiety—Ramipril—hypertension	3.99e-05	0.000288	CcSEcCtD
Midodrine—Somnolence—Losartan—hypertension	3.98e-05	0.000288	CcSEcCtD
Midodrine—Dizziness—Eplerenone—hypertension	3.98e-05	0.000288	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	3.98e-05	0.000287	CcSEcCtD
Midodrine—Asthenia—Valsartan—hypertension	3.97e-05	0.000287	CcSEcCtD
Midodrine—Hypertension—Timolol—hypertension	3.97e-05	0.000287	CcSEcCtD
Midodrine—Pain—Furosemide—hypertension	3.97e-05	0.000287	CcSEcCtD
Midodrine—Gastrointestinal disorder—Betaxolol—hypertension	3.97e-05	0.000287	CcSEcCtD
Midodrine—Asthenia—Olmesartan—hypertension	3.95e-05	0.000286	CcSEcCtD
Midodrine—Dizziness—Nifedipine—hypertension	3.95e-05	0.000285	CcSEcCtD
Midodrine—Rash—Indapamide—hypertension	3.95e-05	0.000285	CcSEcCtD
Midodrine—Rash—Diltiazem—hypertension	3.95e-05	0.000285	CcSEcCtD
Midodrine—Dermatitis—Indapamide—hypertension	3.94e-05	0.000285	CcSEcCtD
Midodrine—Dermatitis—Diltiazem—hypertension	3.94e-05	0.000285	CcSEcCtD
Midodrine—Dyspepsia—Losartan—hypertension	3.94e-05	0.000285	CcSEcCtD
Midodrine—Feeling abnormal—Perindopril—hypertension	3.93e-05	0.000284	CcSEcCtD
Midodrine—Dizziness—Verapamil—hypertension	3.93e-05	0.000284	CcSEcCtD
Midodrine—Pain—Betaxolol—hypertension	3.93e-05	0.000284	CcSEcCtD
Midodrine—Feeling abnormal—Irbesartan—hypertension	3.92e-05	0.000283	CcSEcCtD
Midodrine—Headache—Indapamide—hypertension	3.92e-05	0.000283	CcSEcCtD
Midodrine—Headache—Diltiazem—hypertension	3.92e-05	0.000283	CcSEcCtD
Midodrine—Pruritus—Valsartan—hypertension	3.92e-05	0.000283	CcSEcCtD
Midodrine—Dry mouth—Ramipril—hypertension	3.92e-05	0.000283	CcSEcCtD
Midodrine—Rash—Carvedilol—hypertension	3.91e-05	0.000282	CcSEcCtD
Midodrine—Gastrointestinal pain—Perindopril—hypertension	3.9e-05	0.000282	CcSEcCtD
Midodrine—Dermatitis—Carvedilol—hypertension	3.9e-05	0.000282	CcSEcCtD
Midodrine—Anxiety—Timolol—hypertension	3.9e-05	0.000282	CcSEcCtD
Midodrine—Pruritus—Olmesartan—hypertension	3.9e-05	0.000282	CcSEcCtD
Midodrine—Gastrointestinal pain—Irbesartan—hypertension	3.89e-05	0.000281	CcSEcCtD
Midodrine—Feeling abnormal—Hydrochlorothiazide—hypertension	3.89e-05	0.000281	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	3.89e-05	0.000281	CcSEcCtD
Midodrine—Abdominal pain—Captopril—hypertension	3.89e-05	0.000281	CcSEcCtD
Midodrine—Headache—Carvedilol—hypertension	3.88e-05	0.000281	CcSEcCtD
Midodrine—Confusional state—Ramipril—hypertension	3.87e-05	0.00028	CcSEcCtD
Midodrine—Rash—Doxazosin—hypertension	3.86e-05	0.000279	CcSEcCtD
Midodrine—Dermatitis—Doxazosin—hypertension	3.86e-05	0.000279	CcSEcCtD
Midodrine—Gastrointestinal pain—Hydrochlorothiazide—hypertension	3.86e-05	0.000279	CcSEcCtD
Midodrine—Nausea—Propranolol—hypertension	3.84e-05	0.000278	CcSEcCtD
Midodrine—Headache—Doxazosin—hypertension	3.84e-05	0.000277	CcSEcCtD
Midodrine—Dry mouth—Timolol—hypertension	3.83e-05	0.000277	CcSEcCtD
Midodrine—Pain—Losartan—hypertension	3.83e-05	0.000277	CcSEcCtD
Midodrine—Feeling abnormal—Furosemide—hypertension	3.82e-05	0.000276	CcSEcCtD
Midodrine—Rash—Fosinopril—hypertension	3.82e-05	0.000276	CcSEcCtD
Midodrine—Dermatitis—Fosinopril—hypertension	3.81e-05	0.000276	CcSEcCtD
Midodrine—Gastrointestinal pain—Furosemide—hypertension	3.8e-05	0.000274	CcSEcCtD
Midodrine—Rash—Eplerenone—hypertension	3.79e-05	0.000274	CcSEcCtD
Midodrine—Headache—Fosinopril—hypertension	3.79e-05	0.000274	CcSEcCtD
Midodrine—Dermatitis—Eplerenone—hypertension	3.79e-05	0.000274	CcSEcCtD
Midodrine—Asthenia—Clonidine—hypertension	3.79e-05	0.000274	CcSEcCtD
Midodrine—Feeling abnormal—Betaxolol—hypertension	3.79e-05	0.000274	CcSEcCtD
Midodrine—Confusional state—Timolol—hypertension	3.79e-05	0.000274	CcSEcCtD
Midodrine—Abdominal pain—Perindopril—hypertension	3.77e-05	0.000273	CcSEcCtD
Midodrine—Headache—Eplerenone—hypertension	3.77e-05	0.000272	CcSEcCtD
Midodrine—Rash—Nifedipine—hypertension	3.77e-05	0.000272	CcSEcCtD
Midodrine—Nervous system disorder—Ramipril—hypertension	3.77e-05	0.000272	CcSEcCtD
Midodrine—Dermatitis—Nifedipine—hypertension	3.76e-05	0.000272	CcSEcCtD
Midodrine—Abdominal pain—Irbesartan—hypertension	3.76e-05	0.000272	CcSEcCtD
Midodrine—Rash—Verapamil—hypertension	3.75e-05	0.000271	CcSEcCtD
Midodrine—Tachycardia—Ramipril—hypertension	3.75e-05	0.000271	CcSEcCtD
Midodrine—Dermatitis—Verapamil—hypertension	3.75e-05	0.000271	CcSEcCtD
Midodrine—Headache—Nifedipine—hypertension	3.74e-05	0.00027	CcSEcCtD
Midodrine—Pruritus—Clonidine—hypertension	3.73e-05	0.00027	CcSEcCtD
Midodrine—Abdominal pain—Hydrochlorothiazide—hypertension	3.73e-05	0.00027	CcSEcCtD
Midodrine—Skin disorder—Ramipril—hypertension	3.73e-05	0.00027	CcSEcCtD
Midodrine—Headache—Verapamil—hypertension	3.73e-05	0.000269	CcSEcCtD
Midodrine—Nausea—Indapamide—hypertension	3.72e-05	0.000269	CcSEcCtD
Midodrine—Nausea—Diltiazem—hypertension	3.72e-05	0.000269	CcSEcCtD
Midodrine—Asthenia—Trandolapril—hypertension	3.69e-05	0.000267	CcSEcCtD
Midodrine—Feeling abnormal—Losartan—hypertension	3.69e-05	0.000267	CcSEcCtD
Midodrine—Nervous system disorder—Timolol—hypertension	3.68e-05	0.000266	CcSEcCtD
Midodrine—Nausea—Carvedilol—hypertension	3.68e-05	0.000266	CcSEcCtD
Midodrine—Asthenia—Enalapril—hypertension	3.68e-05	0.000266	CcSEcCtD
Midodrine—Abdominal pain—Furosemide—hypertension	3.67e-05	0.000265	CcSEcCtD
Midodrine—Gastrointestinal pain—Losartan—hypertension	3.66e-05	0.000265	CcSEcCtD
Midodrine—Dizziness—Valsartan—hypertension	3.66e-05	0.000265	CcSEcCtD
Midodrine—Skin disorder—Timolol—hypertension	3.65e-05	0.000264	CcSEcCtD
Midodrine—Dizziness—Olmesartan—hypertension	3.64e-05	0.000263	CcSEcCtD
Midodrine—Pruritus—Trandolapril—hypertension	3.64e-05	0.000263	CcSEcCtD
Midodrine—Nausea—Doxazosin—hypertension	3.64e-05	0.000263	CcSEcCtD
Midodrine—Asthenia—Telmisartan—hypertension	3.63e-05	0.000262	CcSEcCtD
Midodrine—Pruritus—Enalapril—hypertension	3.63e-05	0.000262	CcSEcCtD
Midodrine—Anxiety—Lisinopril—hypertension	3.62e-05	0.000262	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	3.61e-05	0.000261	CcSEcCtD
Midodrine—Nausea—Fosinopril—hypertension	3.6e-05	0.00026	CcSEcCtD
Midodrine—Pruritus—Telmisartan—hypertension	3.58e-05	0.000259	CcSEcCtD
Midodrine—Nausea—Eplerenone—hypertension	3.57e-05	0.000258	CcSEcCtD
Midodrine—Dry mouth—Lisinopril—hypertension	3.55e-05	0.000257	CcSEcCtD
Midodrine—Nausea—Nifedipine—hypertension	3.55e-05	0.000256	CcSEcCtD
Midodrine—Abdominal pain—Losartan—hypertension	3.54e-05	0.000256	CcSEcCtD
Midodrine—Nausea—Verapamil—hypertension	3.53e-05	0.000255	CcSEcCtD
Midodrine—Asthenia—Captopril—hypertension	3.53e-05	0.000255	CcSEcCtD
Midodrine—Confusional state—Lisinopril—hypertension	3.51e-05	0.000254	CcSEcCtD
Midodrine—Rash—Valsartan—hypertension	3.49e-05	0.000252	CcSEcCtD
Midodrine—Dizziness—Clonidine—hypertension	3.49e-05	0.000252	CcSEcCtD
Midodrine—Dermatitis—Valsartan—hypertension	3.49e-05	0.000252	CcSEcCtD
Midodrine—Pruritus—Captopril—hypertension	3.48e-05	0.000251	CcSEcCtD
Midodrine—Rash—Olmesartan—hypertension	3.47e-05	0.000251	CcSEcCtD
Midodrine—Insomnia—Ramipril—hypertension	3.47e-05	0.000251	CcSEcCtD
Midodrine—Dermatitis—Olmesartan—hypertension	3.47e-05	0.000251	CcSEcCtD
Midodrine—Headache—Valsartan—hypertension	3.47e-05	0.000251	CcSEcCtD
Midodrine—Headache—Olmesartan—hypertension	3.45e-05	0.000249	CcSEcCtD
Midodrine—Paraesthesia—Ramipril—hypertension	3.45e-05	0.000249	CcSEcCtD
Midodrine—Asthenia—Perindopril—hypertension	3.43e-05	0.000248	CcSEcCtD
Midodrine—Dyspnoea—Ramipril—hypertension	3.42e-05	0.000247	CcSEcCtD
Midodrine—Asthenia—Irbesartan—hypertension	3.41e-05	0.000247	CcSEcCtD
Midodrine—Somnolence—Ramipril—hypertension	3.41e-05	0.000247	CcSEcCtD
Midodrine—Dizziness—Trandolapril—hypertension	3.4e-05	0.000246	CcSEcCtD
Midodrine—Tachycardia—Lisinopril—hypertension	3.4e-05	0.000246	CcSEcCtD
Midodrine—Insomnia—Timolol—hypertension	3.4e-05	0.000245	CcSEcCtD
Midodrine—Dizziness—Enalapril—hypertension	3.39e-05	0.000245	CcSEcCtD
Midodrine—Asthenia—Hydrochlorothiazide—hypertension	3.39e-05	0.000245	CcSEcCtD
Midodrine—Skin disorder—Lisinopril—hypertension	3.38e-05	0.000244	CcSEcCtD
Midodrine—Dyspepsia—Ramipril—hypertension	3.38e-05	0.000244	CcSEcCtD
Midodrine—Pruritus—Perindopril—hypertension	3.38e-05	0.000244	CcSEcCtD
Midodrine—Paraesthesia—Timolol—hypertension	3.37e-05	0.000244	CcSEcCtD
Midodrine—Pruritus—Irbesartan—hypertension	3.37e-05	0.000243	CcSEcCtD
Midodrine—Dyspnoea—Timolol—hypertension	3.35e-05	0.000242	CcSEcCtD
Midodrine—Dizziness—Telmisartan—hypertension	3.34e-05	0.000242	CcSEcCtD
Midodrine—Pruritus—Hydrochlorothiazide—hypertension	3.34e-05	0.000241	CcSEcCtD
Midodrine—Somnolence—Timolol—hypertension	3.34e-05	0.000241	CcSEcCtD
Midodrine—Asthenia—Furosemide—hypertension	3.33e-05	0.000241	CcSEcCtD
Midodrine—Rash—Clonidine—hypertension	3.33e-05	0.000241	CcSEcCtD
Midodrine—Dermatitis—Clonidine—hypertension	3.33e-05	0.00024	CcSEcCtD
Midodrine—Gastrointestinal disorder—Ramipril—hypertension	3.32e-05	0.00024	CcSEcCtD
Midodrine—Headache—Clonidine—hypertension	3.31e-05	0.000239	CcSEcCtD
Midodrine—Dyspepsia—Timolol—hypertension	3.3e-05	0.000239	CcSEcCtD
Midodrine—Asthenia—Betaxolol—hypertension	3.3e-05	0.000238	CcSEcCtD
Midodrine—Nausea—Valsartan—hypertension	3.29e-05	0.000238	CcSEcCtD
Midodrine—Pruritus—Furosemide—hypertension	3.28e-05	0.000237	CcSEcCtD
Midodrine—Nausea—Olmesartan—hypertension	3.27e-05	0.000237	CcSEcCtD
Midodrine—Dizziness—Captopril—hypertension	3.25e-05	0.000235	CcSEcCtD
Midodrine—Pruritus—Betaxolol—hypertension	3.25e-05	0.000235	CcSEcCtD
Midodrine—Rash—Trandolapril—hypertension	3.25e-05	0.000235	CcSEcCtD
Midodrine—Dermatitis—Trandolapril—hypertension	3.24e-05	0.000234	CcSEcCtD
Midodrine—Gastrointestinal disorder—Timolol—hypertension	3.24e-05	0.000234	CcSEcCtD
Midodrine—Rash—Enalapril—hypertension	3.23e-05	0.000234	CcSEcCtD
Midodrine—Dermatitis—Enalapril—hypertension	3.23e-05	0.000233	CcSEcCtD
Midodrine—Headache—Trandolapril—hypertension	3.23e-05	0.000233	CcSEcCtD
Midodrine—Asthenia—Losartan—hypertension	3.21e-05	0.000232	CcSEcCtD
Midodrine—Headache—Enalapril—hypertension	3.21e-05	0.000232	CcSEcCtD
Midodrine—Pain—Timolol—hypertension	3.21e-05	0.000232	CcSEcCtD
Midodrine—Rash—Telmisartan—hypertension	3.19e-05	0.00023	CcSEcCtD
Midodrine—Dermatitis—Telmisartan—hypertension	3.19e-05	0.00023	CcSEcCtD
Midodrine—Pruritus—Losartan—hypertension	3.17e-05	0.000229	CcSEcCtD
Midodrine—Headache—Telmisartan—hypertension	3.17e-05	0.000229	CcSEcCtD
Midodrine—Feeling abnormal—Ramipril—hypertension	3.16e-05	0.000229	CcSEcCtD
Midodrine—Dizziness—Perindopril—hypertension	3.16e-05	0.000228	CcSEcCtD
Midodrine—Insomnia—Lisinopril—hypertension	3.15e-05	0.000228	CcSEcCtD
Midodrine—Dizziness—Irbesartan—hypertension	3.15e-05	0.000227	CcSEcCtD
Midodrine—Gastrointestinal pain—Ramipril—hypertension	3.14e-05	0.000227	CcSEcCtD
Midodrine—Nausea—Clonidine—hypertension	3.14e-05	0.000227	CcSEcCtD
Midodrine—Paraesthesia—Lisinopril—hypertension	3.13e-05	0.000226	CcSEcCtD
Midodrine—Dizziness—Hydrochlorothiazide—hypertension	3.12e-05	0.000226	CcSEcCtD
Midodrine—Dyspnoea—Lisinopril—hypertension	3.1e-05	0.000224	CcSEcCtD
Midodrine—Rash—Captopril—hypertension	3.1e-05	0.000224	CcSEcCtD
Midodrine—Dermatitis—Captopril—hypertension	3.1e-05	0.000224	CcSEcCtD
Midodrine—Somnolence—Lisinopril—hypertension	3.1e-05	0.000224	CcSEcCtD
Midodrine—Feeling abnormal—Timolol—hypertension	3.09e-05	0.000224	CcSEcCtD
Midodrine—Headache—Captopril—hypertension	3.08e-05	0.000223	CcSEcCtD
Midodrine—Gastrointestinal pain—Timolol—hypertension	3.07e-05	0.000222	CcSEcCtD
Midodrine—Dizziness—Furosemide—hypertension	3.07e-05	0.000222	CcSEcCtD
Midodrine—Dyspepsia—Lisinopril—hypertension	3.07e-05	0.000222	CcSEcCtD
Midodrine—Nausea—Trandolapril—hypertension	3.06e-05	0.000221	CcSEcCtD
Midodrine—Nausea—Enalapril—hypertension	3.05e-05	0.00022	CcSEcCtD
Midodrine—Dizziness—Betaxolol—hypertension	3.04e-05	0.00022	CcSEcCtD
Midodrine—Abdominal pain—Ramipril—hypertension	3.04e-05	0.000219	CcSEcCtD
Midodrine—Rash—Perindopril—hypertension	3.01e-05	0.000218	CcSEcCtD
Midodrine—Dermatitis—Perindopril—hypertension	3.01e-05	0.000217	CcSEcCtD
Midodrine—Gastrointestinal disorder—Lisinopril—hypertension	3.01e-05	0.000217	CcSEcCtD
Midodrine—Nausea—Telmisartan—hypertension	3e-05	0.000217	CcSEcCtD
Midodrine—Rash—Irbesartan—hypertension	3e-05	0.000217	CcSEcCtD
Midodrine—Dermatitis—Irbesartan—hypertension	3e-05	0.000217	CcSEcCtD
Midodrine—Headache—Perindopril—hypertension	2.99e-05	0.000216	CcSEcCtD
Midodrine—Headache—Irbesartan—hypertension	2.98e-05	0.000215	CcSEcCtD
Midodrine—Pain—Lisinopril—hypertension	2.98e-05	0.000215	CcSEcCtD
Midodrine—Rash—Hydrochlorothiazide—hypertension	2.98e-05	0.000215	CcSEcCtD
Midodrine—Dermatitis—Hydrochlorothiazide—hypertension	2.97e-05	0.000215	CcSEcCtD
Midodrine—Abdominal pain—Timolol—hypertension	2.97e-05	0.000214	CcSEcCtD
Midodrine—Dizziness—Losartan—hypertension	2.96e-05	0.000214	CcSEcCtD
Midodrine—Headache—Hydrochlorothiazide—hypertension	2.96e-05	0.000214	CcSEcCtD
Midodrine—Rash—Furosemide—hypertension	2.93e-05	0.000211	CcSEcCtD
Midodrine—Dermatitis—Furosemide—hypertension	2.92e-05	0.000211	CcSEcCtD
Midodrine—Nausea—Captopril—hypertension	2.92e-05	0.000211	CcSEcCtD
Midodrine—Headache—Furosemide—hypertension	2.91e-05	0.00021	CcSEcCtD
Midodrine—Rash—Betaxolol—hypertension	2.9e-05	0.000209	CcSEcCtD
Midodrine—Dermatitis—Betaxolol—hypertension	2.89e-05	0.000209	CcSEcCtD
Midodrine—Headache—Betaxolol—hypertension	2.88e-05	0.000208	CcSEcCtD
Midodrine—Feeling abnormal—Lisinopril—hypertension	2.87e-05	0.000207	CcSEcCtD
Midodrine—Gastrointestinal pain—Lisinopril—hypertension	2.85e-05	0.000206	CcSEcCtD
Midodrine—Nausea—Perindopril—hypertension	2.84e-05	0.000205	CcSEcCtD
Midodrine—Nausea—Irbesartan—hypertension	2.83e-05	0.000204	CcSEcCtD
Midodrine—Rash—Losartan—hypertension	2.82e-05	0.000204	CcSEcCtD
Midodrine—Dermatitis—Losartan—hypertension	2.82e-05	0.000204	CcSEcCtD
Midodrine—Headache—Losartan—hypertension	2.81e-05	0.000203	CcSEcCtD
Midodrine—Nausea—Hydrochlorothiazide—hypertension	2.8e-05	0.000203	CcSEcCtD
Midodrine—Nausea—Furosemide—hypertension	2.76e-05	0.000199	CcSEcCtD
Midodrine—Asthenia—Ramipril—hypertension	2.76e-05	0.000199	CcSEcCtD
Midodrine—Abdominal pain—Lisinopril—hypertension	2.75e-05	0.000199	CcSEcCtD
Midodrine—Nausea—Betaxolol—hypertension	2.73e-05	0.000197	CcSEcCtD
Midodrine—Pruritus—Ramipril—hypertension	2.72e-05	0.000196	CcSEcCtD
Midodrine—Asthenia—Timolol—hypertension	2.69e-05	0.000195	CcSEcCtD
Midodrine—Nausea—Losartan—hypertension	2.66e-05	0.000192	CcSEcCtD
Midodrine—Pruritus—Timolol—hypertension	2.66e-05	0.000192	CcSEcCtD
Midodrine—Dizziness—Ramipril—hypertension	2.54e-05	0.000184	CcSEcCtD
Midodrine—Asthenia—Lisinopril—hypertension	2.5e-05	0.000181	CcSEcCtD
Midodrine—Dizziness—Timolol—hypertension	2.48e-05	0.000179	CcSEcCtD
Midodrine—Pruritus—Lisinopril—hypertension	2.46e-05	0.000178	CcSEcCtD
Midodrine—Rash—Ramipril—hypertension	2.42e-05	0.000175	CcSEcCtD
Midodrine—Dermatitis—Ramipril—hypertension	2.42e-05	0.000175	CcSEcCtD
Midodrine—Headache—Ramipril—hypertension	2.41e-05	0.000174	CcSEcCtD
Midodrine—Rash—Timolol—hypertension	2.37e-05	0.000171	CcSEcCtD
Midodrine—Dermatitis—Timolol—hypertension	2.36e-05	0.000171	CcSEcCtD
Midodrine—Headache—Timolol—hypertension	2.35e-05	0.00017	CcSEcCtD
Midodrine—Dizziness—Lisinopril—hypertension	2.3e-05	0.000166	CcSEcCtD
Midodrine—Nausea—Ramipril—hypertension	2.28e-05	0.000165	CcSEcCtD
Midodrine—Nausea—Timolol—hypertension	2.23e-05	0.000161	CcSEcCtD
Midodrine—Rash—Lisinopril—hypertension	2.2e-05	0.000159	CcSEcCtD
Midodrine—Dermatitis—Lisinopril—hypertension	2.19e-05	0.000159	CcSEcCtD
Midodrine—Headache—Lisinopril—hypertension	2.18e-05	0.000158	CcSEcCtD
Midodrine—Nausea—Lisinopril—hypertension	2.07e-05	0.000149	CcSEcCtD
Midodrine—ADRA1A—Signaling by GPCR—POMC—hypertension	3.69e-06	5e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALDH2—hypertension	3.68e-06	4.99e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRL—hypertension	3.68e-06	4.99e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGTR1—hypertension	3.68e-06	4.99e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—RHOA—hypertension	3.66e-06	4.96e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GNAS—hypertension	3.64e-06	4.94e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HDAC1—hypertension	3.63e-06	4.91e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—STK11—hypertension	3.63e-06	4.91e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3R1—hypertension	3.62e-06	4.91e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCL2—hypertension	3.61e-06	4.89e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PDGFB—hypertension	3.6e-06	4.88e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL10—hypertension	3.6e-06	4.87e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HBA1—hypertension	3.59e-06	4.87e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PLG—hypertension	3.59e-06	4.86e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—RHOA—hypertension	3.58e-06	4.85e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FGFR1—hypertension	3.58e-06	4.85e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP11A1—hypertension	3.57e-06	4.84e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOB—hypertension	3.57e-06	4.84e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PTK2—hypertension	3.55e-06	4.82e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT2—hypertension	3.55e-06	4.81e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3R1—hypertension	3.54e-06	4.8e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCL8—hypertension	3.54e-06	4.79e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HIF1A—hypertension	3.52e-06	4.78e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AGT—hypertension	3.51e-06	4.76e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EDN1—hypertension	3.51e-06	4.76e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTT1—hypertension	3.5e-06	4.75e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SLC9A1—hypertension	3.5e-06	4.75e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRB2—hypertension	3.49e-06	4.73e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL5—hypertension	3.48e-06	4.72e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GCLC—hypertension	3.46e-06	4.69e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CETP—hypertension	3.46e-06	4.69e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CALM1—hypertension	3.45e-06	4.68e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCE—hypertension	3.45e-06	4.67e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LEP—hypertension	3.44e-06	4.66e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOE—hypertension	3.44e-06	4.66e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CAV1—hypertension	3.41e-06	4.62e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LPL—hypertension	3.41e-06	4.62e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PDGFA—hypertension	3.4e-06	4.61e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—VAV3—hypertension	3.4e-06	4.61e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOA1—hypertension	3.4e-06	4.61e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—H2AFX—hypertension	3.38e-06	4.58e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PDGFRB—hypertension	3.38e-06	4.58e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RPS6KB1—hypertension	3.38e-06	4.58e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—KDR—hypertension	3.37e-06	4.57e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TGFBR2—hypertension	3.35e-06	4.55e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADCY5—hypertension	3.34e-06	4.52e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GNB3—hypertension	3.32e-06	4.5e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP17A1—hypertension	3.32e-06	4.5e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCG—hypertension	3.31e-06	4.49e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ITGB3—hypertension	3.29e-06	4.46e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCA—hypertension	3.29e-06	4.46e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ENO1—hypertension	3.28e-06	4.45e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS1—hypertension	3.28e-06	4.45e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AVP—hypertension	3.28e-06	4.44e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—YWHAZ—hypertension	3.26e-06	4.42e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—RHOA—hypertension	3.25e-06	4.41e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FN1—hypertension	3.24e-06	4.4e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—F2—hypertension	3.24e-06	4.4e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PRKCB—hypertension	3.24e-06	4.4e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GNAS—hypertension	3.24e-06	4.39e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NGF—hypertension	3.23e-06	4.37e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SPP1—hypertension	3.23e-06	4.37e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3R1—hypertension	3.22e-06	4.36e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCL8—hypertension	3.21e-06	4.35e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NOTCH1—hypertension	3.18e-06	4.3e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOB—hypertension	3.17e-06	4.3e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CTGF—hypertension	3.16e-06	4.28e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PTK2—hypertension	3.16e-06	4.28e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCL8—hypertension	3.14e-06	4.26e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCR5—hypertension	3.14e-06	4.25e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCD—hypertension	3.14e-06	4.25e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMGCR—hypertension	3.13e-06	4.25e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GOT2—hypertension	3.13e-06	4.25e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EDN1—hypertension	3.12e-06	4.23e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL5—hypertension	3.09e-06	4.19e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR2A—hypertension	3.07e-06	4.16e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—C3—hypertension	3.07e-06	4.16e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ADRA2A—hypertension	3.07e-06	4.15e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LPL—hypertension	3.03e-06	4.1e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—H2AFX—hypertension	3e-06	4.07e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RPS6KB1—hypertension	3e-06	4.06e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PDGFRB—hypertension	3e-06	4.06e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PDGFB—hypertension	2.99e-06	4.05e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FGFR1—hypertension	2.97e-06	4.03e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADCY5—hypertension	2.96e-06	4.01e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—POMC—hypertension	2.96e-06	4.01e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCG—hypertension	2.94e-06	3.99e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—INS—hypertension	2.94e-06	3.98e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HIF1A—hypertension	2.93e-06	3.96e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCA—hypertension	2.92e-06	3.96e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ITGB3—hypertension	2.92e-06	3.96e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AGT—hypertension	2.91e-06	3.95e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—YWHAZ—hypertension	2.9e-06	3.93e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL2—hypertension	2.89e-06	3.92e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TH—hypertension	2.87e-06	3.89e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SPP1—hypertension	2.87e-06	3.88e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NGF—hypertension	2.87e-06	3.88e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CALM1—hypertension	2.87e-06	3.88e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CALM2—hypertension	2.86e-06	3.88e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOE—hypertension	2.86e-06	3.87e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LEP—hypertension	2.86e-06	3.87e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCL8—hypertension	2.85e-06	3.87e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF1—hypertension	2.84e-06	3.85e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT2—hypertension	2.84e-06	3.85e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CAV1—hypertension	2.83e-06	3.83e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—EGFR—hypertension	2.83e-06	3.83e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOA1—hypertension	2.82e-06	3.83e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—KDR—hypertension	2.8e-06	3.79e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SLC2A4—hypertension	2.79e-06	3.78e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GCG—hypertension	2.79e-06	3.78e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCR5—hypertension	2.79e-06	3.78e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCD—hypertension	2.79e-06	3.78e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR2A—hypertension	2.73e-06	3.7e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—C3—hypertension	2.72e-06	3.69e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GOT1—hypertension	2.7e-06	3.67e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SERPINE1—hypertension	2.7e-06	3.66e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCB—hypertension	2.69e-06	3.65e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FN1—hypertension	2.69e-06	3.65e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—F2—hypertension	2.69e-06	3.65e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PDGFB—hypertension	2.65e-06	3.59e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGFR1—hypertension	2.64e-06	3.58e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NOTCH1—hypertension	2.64e-06	3.57e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP19A1—hypertension	2.63e-06	3.56e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—STK11—hypertension	2.63e-06	3.56e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FGF2—hypertension	2.61e-06	3.54e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RHOA—hypertension	2.6e-06	3.53e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HIF1A—hypertension	2.6e-06	3.52e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGT—hypertension	2.59e-06	3.51e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NOS3—hypertension	2.58e-06	3.49e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3R1—hypertension	2.58e-06	3.49e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CALM1—hypertension	2.55e-06	3.45e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOE—hypertension	2.54e-06	3.44e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LEP—hypertension	2.54e-06	3.44e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CAV1—hypertension	2.51e-06	3.41e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOA1—hypertension	2.51e-06	3.4e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—KDR—hypertension	2.49e-06	3.37e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—POMC—hypertension	2.45e-06	3.32e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—COMT—hypertension	2.44e-06	3.31e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—INS—hypertension	2.44e-06	3.31e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RELA—hypertension	2.43e-06	3.29e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GNB3—hypertension	2.41e-06	3.26e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARGC1A—hypertension	2.41e-06	3.26e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL2—hypertension	2.4e-06	3.25e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMOX1—hypertension	2.4e-06	3.25e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FN1—hypertension	2.39e-06	3.24e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—F2—hypertension	2.39e-06	3.24e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCB—hypertension	2.39e-06	3.24e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MTOR—hypertension	2.38e-06	3.22e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CAT—hypertension	2.36e-06	3.2e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF1—hypertension	2.36e-06	3.2e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT2—hypertension	2.36e-06	3.2e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—EGFR—hypertension	2.35e-06	3.18e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GNAS—hypertension	2.34e-06	3.18e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NOTCH1—hypertension	2.34e-06	3.17e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOB—hypertension	2.29e-06	3.11e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCL8—hypertension	2.29e-06	3.1e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SERPINE1—hypertension	2.24e-06	3.04e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTM1—hypertension	2.23e-06	3.03e-05	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—AKT1—hypertension	2.21e-06	2.99e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LPL—hypertension	2.19e-06	2.97e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—POMC—hypertension	2.18e-06	2.95e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—hypertension	2.17e-06	2.95e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FGF2—hypertension	2.17e-06	2.94e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—INS—hypertension	2.17e-06	2.94e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RHOA—hypertension	2.16e-06	2.93e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ADCY5—hypertension	2.15e-06	2.91e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NOS3—hypertension	2.14e-06	2.9e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3R1—hypertension	2.14e-06	2.9e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GPX1—hypertension	2.14e-06	2.9e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL2—hypertension	2.13e-06	2.89e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PRKCA—hypertension	2.12e-06	2.87e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP1A1—hypertension	2.12e-06	2.87e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF1—hypertension	2.1e-06	2.84e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT2—hypertension	2.09e-06	2.84e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—EGFR—hypertension	2.09e-06	2.83e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CD36—hypertension	2.08e-06	2.82e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MMP9—hypertension	2.07e-06	2.8e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CDKN1A—hypertension	2.06e-06	2.79e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PTEN—hypertension	2.06e-06	2.79e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RELA—hypertension	2.01e-06	2.73e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAPK8—hypertension	2.01e-06	2.73e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AKT1—hypertension	2.01e-06	2.72e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SERPINE1—hypertension	1.99e-06	2.7e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MTOR—hypertension	1.97e-06	2.68e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MTHFR—hypertension	1.97e-06	2.67e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—EP300—hypertension	1.96e-06	2.66e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARA—hypertension	1.94e-06	2.62e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGF2—hypertension	1.93e-06	2.61e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RHOA—hypertension	1.92e-06	2.6e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SRC—hypertension	1.91e-06	2.58e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3R1—hypertension	1.9e-06	2.58e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NOS3—hypertension	1.9e-06	2.58e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL8—hypertension	1.9e-06	2.57e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AGT—hypertension	1.87e-06	2.54e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—VEGFA—hypertension	1.86e-06	2.52e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CALM1—hypertension	1.84e-06	2.5e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOE—hypertension	1.84e-06	2.49e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AKT1—hypertension	1.83e-06	2.48e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CAV1—hypertension	1.82e-06	2.47e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOA1—hypertension	1.82e-06	2.46e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—hypertension	1.8e-06	2.45e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RELA—hypertension	1.79e-06	2.42e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MTOR—hypertension	1.75e-06	2.38e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP9—hypertension	1.72e-06	2.33e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CDKN1A—hypertension	1.71e-06	2.32e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MYC—hypertension	1.71e-06	2.32e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PTEN—hypertension	1.71e-06	2.31e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TGFB1—hypertension	1.7e-06	2.31e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL8—hypertension	1.69e-06	2.28e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—EGFR—hypertension	1.67e-06	2.26e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAPK8—hypertension	1.67e-06	2.26e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AKT1—hypertension	1.66e-06	2.26e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AKT1—hypertension	1.63e-06	2.21e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EP300—hypertension	1.63e-06	2.21e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—hypertension	1.6e-06	2.17e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARG—hypertension	1.6e-06	2.17e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SRC—hypertension	1.58e-06	2.14e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—POMC—hypertension	1.58e-06	2.14e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—INS—hypertension	1.57e-06	2.13e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—VEGFA—hypertension	1.54e-06	2.09e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP9—hypertension	1.52e-06	2.07e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CDKN1A—hypertension	1.52e-06	2.06e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PTEN—hypertension	1.52e-06	2.05e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAPK8—hypertension	1.48e-06	2.01e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT1—hypertension	1.48e-06	2e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EP300—hypertension	1.45e-06	1.96e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALB—hypertension	1.44e-06	1.95e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MYC—hypertension	1.42e-06	1.92e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TGFB1—hypertension	1.41e-06	1.92e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SRC—hypertension	1.41e-06	1.91e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TP53—hypertension	1.4e-06	1.9e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EGFR—hypertension	1.39e-06	1.88e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3R1—hypertension	1.38e-06	1.86e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NOS3—hypertension	1.38e-06	1.86e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—VEGFA—hypertension	1.37e-06	1.86e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—hypertension	1.28e-06	1.74e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MYC—hypertension	1.26e-06	1.71e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS2—hypertension	1.26e-06	1.71e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TGFB1—hypertension	1.26e-06	1.7e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EGFR—hypertension	1.23e-06	1.67e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT1—hypertension	1.18e-06	1.61e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TP53—hypertension	1.16e-06	1.58e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTEN—hypertension	1.1e-06	1.49e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—hypertension	1.07e-06	1.44e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—EP300—hypertension	1.05e-06	1.42e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TP53—hypertension	1.03e-06	1.4e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT1—hypertension	9.83e-07	1.33e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—hypertension	9.47e-07	1.28e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT1—hypertension	8.74e-07	1.18e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKT1—hypertension	6.33e-07	8.57e-06	CbGpPWpGaD
